Sunil Pharma Private Limited - Company Profile

It is a business services private limited company based in Palam Colony, Delhi, India, established in 2012.
2012 Palam Colony, Delhi, India Struck Off
Last Updated:
About Sunil Pharma Private Limited

Sunil Pharma Private Limited, a struck off private limited company, was established on 22 November 2012 in Palam Colony, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900DL2012PTC245174. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Rekha Aggarwal (Director), Sunil Kumar Aggarwal (Director). Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at Rz-1106A/4, Gali No-12, Sadh Nagar, Palam Colony, Delhi, 110045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900DL2012PTC245174

  • Registration Number

    245174

  • Incorporation Date

    22 November 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Sunil Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sunil Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sunil Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rekha Aggarwal Director 22 Nov 2012 Current
Sunil Kumar Aggarwal Director 22 Nov 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunil Pharma.

Enhance accessibility to Sunil Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sunil Pharma revenue growth over time
Sunil Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunil Pharma?

Unlock access to Sunil Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sunil Pharma?

Unlock and access historical data on people associated with Sunil Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunil Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunil Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sunil Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Sunil Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was completed.

  • Director Appointment

    The activity Rekha Aggarwal was appointed as a Director was appointed as a Director on 22 Nov 2012 & has been associated with this company since 13 years 2 months . was completed.

  • Director Appointment

    Sunil Kumar Aggarwal was appointed as a Director was appointed as a Director on 22 Nov 2012 & has been associated with this company since 13 years 2 months . was recorded as a recent event.

  • Company Incorporation

    Sunil Pharma Private Limited was registered on 22 Nov 2012 with Roc Delhi & aged 13 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunil Pharma Private Limited?

The CIN of Sunil Pharma Private Limited is U74900DL2012PTC245174.

Where is Sunil Pharma Private Limited headquartered?

Sunil Pharma Private Limited is headquartered at Rz-1106A/4, Gali No-12, Sadh Nagar, Palam Colony, Delhi, 110045.

When was Sunil Pharma Private Limited incorporated?

Sunil Pharma Private Limited was incorporated on 22 November 2012.

Who are the current directors of Sunil Pharma Private Limited?

The current directors of Sunil Pharma Private Limited are

What is the primary industry of Sunil Pharma Private Limited?

The primary industry of Sunil Pharma Private Limited is Business Services.

Is Sunil Pharma Private Limited a listed company?

Sunil Pharma Private Limited is unlisted.

What is the capital structure of Sunil Pharma Private Limited?

The authorized capital of Sunil Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sunil Pharma Private Limited?

The compliance status of Sunil Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available